Northern Trust
CRBU icon

Northern Trust’s Caribou Biosciences CRBU Stock Holding History

Northern Trust’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
712,965
+495,230
+227% +$979K ﹤0.01% 3379
2026
Q1 		$414K Hold
217,735
– – ﹤0.01% 3690
2025
Q4 		$346K Buy
217,735
+12,663
+6% +$26.6K ﹤0.01% 3784
2025
Q3 		$478K Sell
205,072
-6,916
-3% -$13.1K ﹤0.01% 3658
2025
Q2 		$267K Sell
211,988
-450,055
-68% -$443K ﹤0.01% 3840
2025
Q1 		$605K Sell
662,043
-52,694
-7% -$68.5K ﹤0.01% 3496
2024
Q4 		$1.14M Buy
714,737
+23,531
+3% +$47.3K ﹤0.01% 3337
2024
Q3 		$1.35M Sell
691,206
-18,923
-3% -$38.7K ﹤0.01% 3218
2024
Q2 		$1.16M Sell
710,129
-24,136
-3% -$77.1K ﹤0.01% 3175
2024
Q1 		$3.77M Sell
734,265
-23,097
-3% -$142K ﹤0.01% 2641
2023
Q4 		$4.34M Buy
757,362
+70,197
+10% +$347K ﹤0.01% 2581
2023
Q3 		$3.28M Buy
687,165
+155,181
+29% +$963K ﹤0.01% 2675
2023
Q2 		$2.26M Buy
531,984
+2,979
+0.6% +$13.4K ﹤0.01% 2940
2023
Q1 		$2.81M Sell
529,005
-5,482
-1% -$34.1K ﹤0.01% 2792
2022
Q4 		$3.36M Buy
534,487
+11,329
+2% +$101K ﹤0.01% 2713
2022
Q3 		$5.52M Buy
523,158
+73,078
+16% +$681K ﹤0.01% 2420
2022
Q2 		$2.44M Buy
450,080
+46,310
+11% +$354K ﹤0.01% 2947
2022
Q1 		$3.71M Buy
403,770
+219,683
+119% +$2.31M ﹤0.01% 2757
2021
Q4 		$2.78M Buy
184,087
+11,086
+6% +$216K ﹤0.01% 3052
2021
Q3 		$4.13M Buy
+173,001
New +$4.23M ﹤0.01% 2855

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust's CRBU Position: Q2 2026 in Review

Northern Trust increased its Caribou Biosciences (CRBU) stake by 227% in Q2 2026, buying an estimated $979K and bringing the position to 712,965 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #3379.

Northern Trust first reported a position in CRBU in Q3 2021 and has held it in 20 quarters since. The position peaked at $5.52M in Q3 2022. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Northern Trust held 712,965 shares of Caribou Biosciences worth $1.25M as of Q2 2026.
  • Northern Trust bought 495,230 Caribou Biosciences shares in Q2 2026, an estimated $979K.
  • Caribou Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3379 holding.
  • Northern Trust first reported a position in Caribou Biosciences in Q3 2021 and has held it in 20 quarters since.
  • Northern Trust's Caribou Biosciences position peaked at $5.52M in Q3 2022.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.